Ortho-tag

Executive Summary

Ortho-tag is a San Diego-based medical device and diagnostics company founded in 2016 that is developing a proprietary platform for wireless in-body communication and nanodiagnostics. The technology enables real-time data exchange between digital health applications and smart medical implants without internal batteries, potentially revolutionizing patient monitoring and implant management. The platform aims to connect sensors and devices inside the body to external systems, allowing continuous, battery-free data transmission. Ortho-tag’s approach could reduce the need for invasive procedures to replace batteries and improve the longevity and functionality of implanted devices. The company is privately held and has not disclosed funding details or regulatory milestones. Given the early stage, Ortho-tag faces significant technical and regulatory hurdles, but its innovation addresses a critical need in the growing smart implant market.

Upcoming Catalysts (preview)

• Q1 2027FDA Breakthrough Device Designation35% success
• Q4 2026Series A Funding Round45% success
• Q2 2027First-In-Human Clinical Study Initiation25% success